Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.

Katharine A Whartenby; Peter A Calabresi; Erin McCadden; Bao Nguyen; David Kardian; Tianhong Wang; Claudio Mosse; Drew M Pardoll; Donald Small

doi:10.1073/pnas.0506088102

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.

Identifier:nobleid.org/w1/20260515/07F2C5EE

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/07F2C5EE.svg?ark=w1%2F20260515%2F07F2C5EE)](https://nobleid.org/work/w1/20260515/07F2C5EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Katharine A Whartenby

Claim authorship of this work

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.

Identifier:nobleid.org/w1/20260515/07F2C5EE

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/07F2C5EE.svg?ark=w1%2F20260515%2F07F2C5EE)](https://nobleid.org/work/w1/20260515/07F2C5EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Katharine A Whartenby

Claim authorship of this work